Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07060651 · ClinicalTrials.gov registry record · NA

Characterization of Human Olfactory Amygdala Subregions Exp3

A NA study of Human Olfactory Amygdala Function, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT07060651 is a NA study of Human Olfactory Amygdala Function that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07060651, a NA study of Human Olfactory Amygdala Function, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

We aim to better understand the functions of the subregions of the human amygdala that receive direct projections from the olfactory bulb

Interventions

  • OTHER Present odors to participants while recording and stimulating brain activity

Study Locations (1)

Illinois

  • Northwestern human olfaction lab - Chicago

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2022-01-01
Est. Completion 2026-04-01
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT07060651

The ClinicalTrials.gov registry entry for NCT07060651 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Human Olfactory Amygdala Function appearing as the primary indexed condition, and to 1 intervention - of which Present odors to participants while recording and stimulating brain activity is the first listed.

NCT07060651 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT07060651 about?

NCT07060651 is a clinical study titled "Characterization of Human Olfactory Amygdala Subregions Exp3". We aim to better understand the functions of the subregions of the human amygdala that receive direct projections from the olfactory bulb

What is the current status of trial NCT07060651?

This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2022-01-01. Estimated completion is 2026-04-01.

What conditions does trial NCT07060651 study?

This clinical trial studies the following conditions: Human Olfactory Amygdala Function.

What interventions are being tested in trial NCT07060651?

The interventions under investigation include: Present odors to participants while recording and stimulating brain activity (OTHER).

Who is sponsoring clinical trial NCT07060651?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07060651 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.